Temovate is a prescription-only skin-care product that contains the active ingredient clobetasol propionate, a high-potency topical corticosteroid. It is supplied in a tube containing 15 g or 30 g of cream. In Hong Kong, Temovate is regulated by the Department of Health and is classified as a prescription-only medicine (POM).
The medication works by reducing inflammation, itching, and redness on the skin. It is commonly prescribed for a range of inflammatory dermatoses where strong anti-inflammatory action is required.
Clobetasol propionate belongs to the class of synthetic glucocorticoids. When applied to the skin, it:
These actions lead to rapid relief of erythema, edema, and pruritus. Because the drug is applied topically, systemic absorption is minimal when used as directed, limiting whole-body side effects.
Temovate is FDA/EMA-approved for the same indications recognized in Hong Kong for high-potency topical corticosteroids. Commonly approved uses include:
The medication is intended for adults and children over 12 years when the benefit outweighs potential risks.
These reactions are usually transient and resolve with continued use or after stopping the medication.
If any of these occur, patients should discontinue the product and seek medical evaluation promptly.
Topical clobetasol generally has limited systemic interaction potential. However, caution is advised when used concurrently with:
Patients should inform their healthcare provider of all topical and oral medications, including over-the-counter products and herbal supplements.
This article provides educational information about Temovate and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Temovate is a very potent corticosteroid; routine use on the face is discouraged because the facial skin is thin and prone to atrophy. If a clinician determines facial treatment is necessary, they will prescribe the lowest effective amount and monitor closely.
The duration depends on the size of the treated area. For moderate psoriasis covering about 10 % of body surface area, a 15 g tube may last roughly 2-3 weeks when applied once daily.
Use only if the potential benefit justifies the potential risk to the fetus. Topical corticosteroids can be absorbed systemically, so a healthcare provider should evaluate alternatives first.
Do not use the product if there are noticeable changes in color, texture, or smell, as this may indicate degradation. Contact your pharmacy for a replacement.
Generally, occlusive dressings increase drug absorption and should be avoided unless specifically instructed by a clinician.
Topical clobetasol has minimal systemic interaction, so routine antihistamines (e.g., cetirizine) are not expected to cause problems. Always list all medications for your prescriber.
Temovate is a Class I (super-potent) corticosteroid, whereas most OTC hydrocortisone products are Class VII (mild). Temovate provides stronger and faster anti-inflammatory effects but carries higher risk of side effects.
Yes, Temovate is classified as a prescription-only medicine in Hong Kong and must be dispensed by a licensed pharmacist upon presentation of a valid prescription.
Yes, provided the tube complies with airline liquid restrictions (generally ≤100 ml per container) and is clearly labeled. Keep it in its original packaging to avoid confusion at security.
Sudden cessation after prolonged use may cause rebound inflammation or a flare-up of the underlying skin condition. A gradual taper-reducing frequency or potency-is recommended under medical supervision.
